Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterovirus A71's capsid protein VP2 is essential for virus assembly, host interaction via SCARB2 receptor binding/uncoating steps, immunogenicity through exposed epitopes on its loops ("puff," EF-loop), and modulation of neurovirulent potential through specific amino acid changes. Its conserved regions make it valuable both as a vaccine target/surrogate marker and as an epitope recognized by broadly neutralizing antibodies—supporting ongoing efforts toward pan-enterovirus vaccine design.
Blocking virion-receptor interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus A71 Capsid Protein VP2 (None).